Dec 1, 1977

Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis

Neurology
J L TrotterD E McFarlin

Abstract

An indirect immunoperoxidase technique was used to study by light microscopy the binding of serum from experimental autoimmune myasthenia gravis (EAMG) rabbits to junctionally and extrajunctionally located acetylcholine receptors (AChRs) in human and rat muscles. Binding was restricted to junctional AChR. Alpha bungarotoxin (a-BGT) partially blocked the binding of EAMG serum, while myasthenia gravis serum, carbamylcholine, decamethonium, and tubocurarine did not. A radioimmunoassay showed significant binding of antibodies in EAMG sera to 125l AChR. This binding was not inhibited by a-BGT, nor by carbamylcholine, decamethonium, or tubocurarine. Sera from 10 myasthenia gravis patients did not contain antibodies binding to the 125l AChR. We suggest that EAMG in rabbits induced by Torpedo AChR differs serologically from myasthenia gravis in patients, probably owing to antigenic differences between Torpedo and human AChR, and that antigenic differences also exist between junctional and extrajunctional receptors.

  • References
  • Citations10

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations10

Citations

Mentioned in this Paper

Carboptic
Binding Sites, Antibody
Antigenic Specificity
Immunology
Cholinergic Receptors
Phosphoglycerate Dehydrogenase Activity
Antibody Formation
Autoimmune Diseases
PHGDH wt Allele
Myasthenia Gravis

About this Paper

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.